Clinical Trial Update: DS-3201b in Participants With Lymphomas [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for DS-3201b in participants with lymphoma, including non-Hodgkin lymphoma. The study is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• DS-3201b

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Lymphoma, Malignant, Non-hodgkin Lymphoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING